European Quality Improvement Programme for Acute Coronary Syndromes
NCT ID: NCT00716430
Last Updated: 2008-07-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
3500 participants
INTERVENTIONAL
2007-08-31
2009-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
QI
Quality Improvement Centres
Quality Improvement Programme
Quality Improvement training programme
Non-QI
No Quality Improvement Programme
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Quality Improvement Programme
Quality Improvement training programme
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* New or transient ST or T wave changes on the ECG consistent with acute myocardial ischaemia
* Elevation of troponin or other cardiac markers to levels indicative of myocardial necrosis according to local laboratory values
Exclusion Criteria
* Use of early reperfusion therapy
* Patients \>80 years
* Patients transferred from another hospital
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Uppsala University
OTHER
GlaxoSmithKline
INDUSTRY
Royal Brompton & Harefield NHS Foundation Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Royal Brompton Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier de la region d'Annecy
Annecy, , France
Centre Hospitalier de Chambery
Chambéry, , France
Cardiology dept. B, CHU Hopital G. Montpied
Clermont-Ferrand, , France
CHU de Grenoble
Grenoble, , France
Centre Hospitalier de Riom Guy Thomas
Riom, , France
Hopitaux Drome Nord de Romans-sur-Isere
Romans-sur-Isère, , France
Centre Hospitalier d'Ussel
Ussel, , France
Centre Hospitalier Pierre Bazin
Voiron, , France
Ospedale M. Bufalini
Cesena, , Italy
Ospedale Morgagni-Pierantoni
Forlì, , Italy
Ospedale di Livorno
Livorno, , Italy
Ospedale Generale Provinciale di Macerata
Macerata, , Italy
Ospedale Civile di Mirano
Mirano, , Italy
Szpital w Ciechanowie
Ciechanów, , Poland
Szpital Zachodni
Grodzisk Mazowiecki, , Poland
Szpital w Grojcu
Grójec, , Poland
Swietofrzyskie Centrum Chorob Serca
Kielce, , Poland
Szpital w Plocku
Płock, , Poland
Radomski Szpital Specjalistyczny
Radom, , Poland
Szpital Specjalistyczny SPZOZ w Radom
Radom, , Poland
Szpital w Siedlcach
Siedlce, , Poland
SP CSK- Medical University of Warsaw
Warsaw, , Poland
Szpital we Wloclawku
Włocławek, , Poland
Hospital Universitario Germans Trias
Badalona, , Spain
Hospital del Mar
Barcelona, , Spain
Hospital Universitario Vall d'Hebron
Barcelona, , Spain
Hospital Josep Trueta
Girona, , Spain
Hospital Universitario Joan XXIII
Tarragona, , Spain
Hospital de Terrassa
Terrassa-Barcelona, , Spain
Hospital de Tortosa Virgen de la Cinta
Tortosa, , Spain
Antrim Area Hospital
Antrim, , United Kingdom
Barnet General Hospital
Barnet, , United Kingdom
Basildon Hospital
Essex, , United Kingdom
Warwick Hospital
Warwick, , United Kingdom
Royal Albert Edward Infirmary
Wigan, , United Kingdom
Yeovil District Hospital
Yeovil, , United Kingdom
York District Hospital
York, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Flather MD, Babalis D, Booth J, Bardaji A, Machecourt J, Opolski G, Ottani F, Bueno H, Banya W, Brady AR, Bojestig M, Lindahl B. Cluster-randomized trial to evaluate the effects of a quality improvement program on management of non-ST-elevation acute coronary syndromes: The European Quality Improvement Programme for Acute Coronary Syndromes (EQUIP-ACS). Am Heart J. 2011 Oct;162(4):700-707.e1. doi: 10.1016/j.ahj.2011.07.027.
Flather MD, Booth J, Babalis D, Bueno H, Steg PG, Opolski G, Ottani F, Machecourt J, Bardaji A, Bojestig M, Brady AR, Lindahl B. Improving the management of non-ST elevation acute coronary syndromes: systematic evaluation of a quality improvement programme European QUality Improvement Programme for Acute Coronary Syndrome: the EQUIP-ACS project protocol and design. Trials. 2010 Jan 14;11:5. doi: 10.1186/1745-6215-11-5.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EQUIP-ACS 1
Identifier Type: -
Identifier Source: org_study_id